Literature DB >> 15078723

C-reactive protein in pneumonia: let me try again.

Carlos M Luna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15078723     DOI： 10.1378/chest.125.4.1192

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  10 in total

1.  Biomarkers for community-acquired pneumonia in the emergency department.

Authors:  Todd A Florin; Lilliam Ambroggio
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

2.  Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia.

Authors:  Todd A Florin; Lilliam Ambroggio; Cole Brokamp; Yin Zhang; Mantosh Rattan; Eric Crotty; Michael A Belsky; Sara Krueger; Thomas N Epperson; Andrea Kachelmeyer; Richard Ruddy; Samir S Shah
Journal:  Pediatrics       Date:  2020-05-13       Impact factor: 7.124

Review 3.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

4.  C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome.

Authors:  Rafael Sierra; Jordi Rello; María Angeles Bailén; Encarnación Benítez; Antonio Gordillo; Cristobal León; Sebastián Pedraza
Journal:  Intensive Care Med       Date:  2004-09-11       Impact factor: 17.440

5.  Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].

Authors:  Mirjam Christ-Crain; Nils G Morgenthaler; Daiana Stolz; Christian Müller; Roland Bingisser; Stephan Harbarth; Michael Tamm; Joachim Struck; Andreas Bergmann; Beat Müller
Journal:  Crit Care       Date:  2006-06-28       Impact factor: 9.097

6.  Use of C-reactive protein to tailor antibiotic use: a systematic review and meta-analysis.

Authors:  Dara Petel; Nicholas Winters; Genevieve C Gore; Jesse Papenburg; Marc Beltempo; Jacques Lacroix; Patricia S Fontela
Journal:  BMJ Open       Date:  2018-12-22       Impact factor: 2.692

Review 7.  [Managing lower respiratory tract infections in immunocompetent patients. Definitions, epidemiology, and diagnostic features].

Authors:  F Philippart
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

8.  C-reactive protein testing to reduce antibiotic prescribing for acute respiratory infections in adults: a systematic review and meta-analysis.

Authors:  Kang Zhang; Kai Xie; Chenxi Zhang; Yingjin Liang; Zhanke Chen; Haifeng Wang
Journal:  J Thorac Dis       Date:  2022-01       Impact factor: 2.895

9.  Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency Department.

Authors:  Marilena Minieri; Vito N Di Lecce; Maria Stella Lia; Massimo Maurici; Francesca Leonardis; Susanna Longo; Luca Colangeli; Carla Paganelli; Stefania Levantesi; Alessandro Terrinoni; Vincenzo Malagnino; Domenico J Brunetti; Alfredo Giovannelli; Massimo Pieri; Marco Ciotti; Cartesio D'Agostini; Mariachiara Gabriele; Sergio Bernardini; Jacopo M Legramante
Journal:  Diagnostics (Basel)       Date:  2022-08-15

10.  C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department.

Authors:  Yael Paran; Doron Yablecovitch; Guy Choshen; Ina Zeitlin; Ori Rogowski; Ronen Ben-Ami; Michal Katzir; Hila Saranga; Tovit Rosenzweig; Dan Justo; Yaffa Orbach; Pinhas Halpern; Shlomo Berliner
Journal:  Crit Care       Date:  2009-04-08       Impact factor: 9.097
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.